US to export 10% of COVID-19 vaccines produced for domestic use by July 4

The U.S. will export 10 percent of all COVID-19 vaccines produced for domestic use by July 4, White House COVID-19 adviser Andy Slavitt announced via Twitter May 4.

Advertisement

The announcement comes as demand for COVID-19 vaccines in the U.S. is declining and most people who are enthusiastic about getting vaccinated against COVID-19 have already received a shot. 

As the U.S. recognizes it has secured more than enough shots to administer to its population willing to get vaccinated, the country is starting to share those surplus doses with the world. Mr. Slavitt’s announcement comes 10 days after the U.S. said it will share its 60 million-dose supply of AstraZeneca COVID-19 vaccines with other countries once the vaccine is approved for emergency use by the FDA.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.